Discovery of NKT cells and development of NKT cell-targeted anti-tumor immunotherapy

Masaru Taniguchi, Michishige Harada, Nyambayar Dashtsoodol, Satoshi Kojo

研究成果: Contribution to journalReview article査読

19 被引用数 (Scopus)

抄録

Natural Killer T (NKT) cells are unique lymphocytes characterized by their expression of a single invariant antigen receptor encoded by Vα14Jα18 in mice and Vα24Jα18 in humans, which recognizes glycolipid antigens in association with the monomorphic CD1d molecule. NKT cells mediate adjuvant activity to activate both CD8T cells to kill MHC-positive tumor cells and NK cells to eliminate MHC-negative tumor at the same time in patients, resulting in the complete eradication of tumors without relapse. Therefore, the NKT cell-targeted therapy can be applied to any type of tumor and also to anyone individual, regardless of HLA type. Phase IIa clinical trials on advanced lung cancers and head and neck tumors have been completed and showed significantly prolonged median survival times with only the primary treatment. Another potential treatment option for the future is to use induced pluripotent stem cell (iPS)-derived NKT cells, which induced adjuvant effects on anti-tumor responses, inhibiting in vivo tumor growth in a mouse model.

本文言語英語
ページ(範囲)292-304
ページ数13
ジャーナルProceedings of the Japan Academy Series B: Physical and Biological Sciences
91
7
DOI
出版ステータス出版済み - 2015
外部発表はい

All Science Journal Classification (ASJC) codes

  • 農業および生物科学(全般)
  • 物理学および天文学(全般)

フィンガープリント

「Discovery of NKT cells and development of NKT cell-targeted anti-tumor immunotherapy」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル